Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)343-346
Number of pages4
JournalEndocrinology
Volume155
Issue number2
DOIs
Publication statusPublished - Feb 2014

ASJC Scopus subject areas

  • Endocrinology

Cite this